Organic Letters
Letter
Y. Chem.Eur. J. 2013, 19, 1496. (c) Alla, S. K.; Kumar, R. K.; Sadhu,
P.; Punniyamurthy, T. Org. Lett. 2013, 15, 1334. (d) McGowan, M. A.;
McAvoy, C. Z.; Buchwald, S. L. Org. Lett. 2012, 14, 3800. (e) Wang,
Y.-F.; Chen, H.; Zhu, X.; Chiba, S. J. Am. Chem. Soc. 2012, 134, 11980.
(f) Wang, Y.-F.; Zhu, X.; Chiba, S. J. Am. Chem. Soc. 2012, 134, 3679.
(g) Liu, X.; Fu, H.; Jiang, Y.; Zhao, Y. Angew. Chem., Int. Ed. 2009, 48,
348. (h) Brasche, G.; Buchwald, S. L. Angew. Chem., Int. Ed. 2008, 47,
1932.
(4) For examples of amidine syntheses related to the Pinner reaction,
see: (a) Boyd, G. V. In The Chemistry of Amidines and Imidates; Patai,
S., Rappoport, Z., Eds.; Wiley: New York, 1991. (b) Dunn, P. J.
Amidines and N-Substituted Amidines. In Comprehensive Organic
Functional Group Transformations II; Katritzky, A. R., Taylor, R. J. K.,
Eds.; Elsevier: New York, 2005; Vol. 5, pp 655−699. (c) Wang, J.; Xu,
F.; Cai, T.; Shen, Q. Org. Lett. 2008, 10, 445. (d) Katritzky, A. R.; Cai,
C.; Singh, S. K. J. Org. Chem. 2006, 71, 3375.
(5) For other examples of amidine syntheses that require the use of
nucleophilic amines, see: (a) DeKorver, K. A.; Johnson, W. L.; Zhang,
Y.; Hsung, R. P.; Dai, H.; Deng, J.; Lohse, A. G.; Zhang, Y.-S. J. Org.
Chem. 2011, 76, 5092. (b) Bae, I.; Han, H.; Chang, S. J. Am. Chem. Soc.
2005, 127, 2038. (c) Chang, S.; Lee, M.; Jung, D. Y.; Yoo, E. J.; Cho, S.
H.; Han, S. K. J. Am. Chem. Soc. 2006, 128, 12366. (d) Kissounko, D.
A.; Hoerter, J. M.; Guzei, I. A.; Cui, Q.; Gellman, S. H.; Stahl, S. S. J.
Am. Chem. Soc. 2007, 129, 1776.
the amidine synthesis described above as a simple method for
accessing functionalizable amidines that can be easily converted
to more complicated compounds through the reactivity of the
enamine functionality. The fact that compound 20 is
structurally similar to cyclohexene nucleoside analogues
suggests that these transformations may be applicable to a
variety of medicinal targets.16
In summary, we have discovered a new method for the
synthesis of N-styrenyl amidines by the addition of α,β-
unsaturated nitrones to isocyanates. This transformation
provides a new route to N-alkenyl amidines which are
challenging to access by traditional methods for amidine
synthesis. Preliminary mechanistic studies suggest that this
transformation proceeds through an initial cycloaddition of a
nitrone to an isocyanate to form an oxadiazolidinone followed
by a subsequent CO2 elimination and styrenyl migration.
Ongoing studies in our lab are aimed at expanding the scope of
the migratory alkenyl group through a better understanding of
the mechanism for CO2 elimination and migration, as well as
developing synthetic applications that exploit N-styrenyl
amidines as synthetic intermediates.
(6) Focken, T.; Charette, A. B. Org. Lett. 2006, 8, 2985.
(7) Fleury, L. M.; Wilson, E. E.; Vogt, M.; Fan, T. J.; Oliver, A. G.;
Ashfeld, B. L. Angew. Chem., Int. Ed. 2013, 52, 11589.
ASSOCIATED CONTENT
* Supporting Information
■
S
(8) (a) Mo, D.-L.; Wink, D. A.; Anderson, L. L. Org. Lett. 2012, 14,
5180. (b) Mo, D.-L.; Anderson, L. L. Angew. Chem., Int. Ed. 2013, 52,
6722.
(9) For examples of [3 + 2] cycloaddition of nitrones and isocyanates
to form oxadiazolidinones, see: (a) Ritter, T.; Carreira, E. M. Angew.
Chem., Int. Ed. 2005, 44, 936. (b) Bell, A. M. T.; Bridges, J.; Cross, R.;
Falshaw, C. P.; Taylor, B. F.; Taylor, G. A.; Whittaker, I. C.; Begley, M.
J. J. Chem. Soc., Perkin Trans. 1 1987, 2593.
Experimental procedures and compound characterization data.
This material is available free of charge via the Internet at
AUTHOR INFORMATION
Corresponding Author
■
Notes
(10) Structural assignment of 9a was verified by X-ray crystallog-
raphy: CCDC 1004695.
(11) When the transformation was run in THF for 36 h, only 8a was
observed. The THF did not contain an inhibitor.
The authors declare no competing financial interest.
(12) Nitrones 6a−6m and 6o−6v were prepared as a >95:5 mixture
of E/Z isomers and separated by chromatography to give only the E-
isomer. See ref 8b and the Supporting Information for details. Nitrone
6n was prepared as a 4:1 mixture of E/Z isomers as described in:
Hood, T. S.; Huels, C. B.; Yang, J. Tetrahedron Lett. 2012, 53, 4679.
(13) Diagnostic styrenyl 1H NMR resonances match spectral data for
N-aryl-N-electron-withdrawing group substituted enamines. See:
Nocquet-Thibault, S.; Retailleau, P.; Cariou, K.; Dodd, R. H. Org.
Lett. 2013, 15, 1842.
ACKNOWLEDGMENTS
■
We acknowledge generous funding from ACS-PRF (DNI-
50491), NSF (NSF-CHE 1212895), and the University of
Illinois at Chicago. We also thank Prof. T. Driver (UIC) for
insightful discussions and Mr. Furong Sun (UIUC) for mass
spectrometry data.
REFERENCES
■
(14) No starting material was recovered, no evidence of aryl
migration was observed, and only decomposition products were
isolated.
(1) For examples of biologically active amidines, see: (a) Doveston,
R. G.; Steendam, R.; Jones, S.; Taylor, R. J. K. Org. Lett. 2012, 14,
1122. (b) Kennedy, A. J.; Mathews, T. P.; Kharel, Y.; Field, S. D.;
Moyer, M. L.; East, J. E.; Houck, J. D.; Lynch, K. R.; Macdonald, T. L.
(15) N-Aryl-α,β-unsaturated nitrones with ortho-substitution on the
N-aryl substituent were not tolerated by our Cu-mediated nitrone
synthesis (see ref 12) and are not accessible by other methods.
(16) For examples of syntheses and medicinal chemistry studies of
similar cyclohexene nucleoside analogues, see: (a) Nauwelaerts, K.;
Fisher, M.; Froeyen, M.; Lescrinier, E.; Van Aerschot, A.; Xu, D.;
DeLong, R.; Kang, H.; Juliano, R. L.; Herdewijn, P. J. Am. Chem. Soc.
2007, 129, 9340. (b) Wang, J.; Herdewijn, P. J. Org. Chem. 1999, 64,
7820. (c) Dalencon, S.; Youcef, R. A.; Pipelier, M.; Maisonneuve, V.;
Dubreuil, D.; Huet, F.; Legoupy, S. J. Org. Chem. 2011, 76, 8059.
̌
̌ ̌
J. Med. Chem. 2011, 54, 3524. (c) Ilas, J.; Jakopin, Z.; Borstnar, T.;
Stegnar, M.; Kikelj, D. J. Med. Chem. 2008, 51, 5617. (d) Edwards, P.
D.; Albert, J. S.; Sylvester, M.; Aharony, D.; Andisik, D.; Callaghan, O.;
Campbell, J. B.; Carr, R. A.; Chessari, G.; Congreve, M.; Frederickson,
M.; Folmer, R. H. A.; Geschwindner, S.; Koether, G.; Kolmodin, K.;
Krumrine, J.; Mauger, R. C.; Murray, C. W.; Olsson, L.-L.; Patel, S.;
̌ ̌
Spear, N.; Tian, G. J. Med. Chem. 2007, 50, 5912. (e) Peterlin-Masic,
L.; Kikelj, D. Tetrahedron 2001, 57, 7073. (f) Rahmathullah, S. M.;
Hall, J. E.; Bender, B. C.; McCurdy, D. R.; Tidwell, R. R.; Boykin, D.
W. J. Med. Chem. 1999, 42, 3994.
(2) For examples of increased cytotoxicity upon replacement of an
́
amide with an amidine, see: (a) Boger, D. L.; Santillan, A., Jr.; Searcey,
M.; Jin, Q. J. Org. Chem. 1999, 64, 5241. (b) Boger, D. L.; Johnson, D.
S. Angew. Chem., Int. Ed. Engl. 1996, 35, 1438.
(3) For examples of the use of amidines in the synthesis of
heterocycles, see: (a) Sheng, J.; Chao, B.; Chen, H.; Hu, Y. H. Org.
Lett. 2013, 15, 4508. (b) Li, S.; Li, Z.; Yuan, Y.; Li, Y.; Zhang, L.; Wu,
3699
dx.doi.org/10.1021/ol501503a | Org. Lett. 2014, 16, 3696−3699